U. Denison et al., INFLUENCE OF ADJUVANT HORMONAL-THERAPY ON THE WHOLE FEMALE ORGANISM -BENEFIT VERSUS POTENTIAL INJURY, Gynakologisch-geburtshilfliche Rundschau, 38(2), 1998, pp. 96-100
Not only do patients suffering from hormone receptor-positive tumors o
f the mammary gland show an increased survival rate, but patients with
endometrial as well as ovarian cancer also benefit from hormone repla
cement therapy. On the one hand, hormonal treatment as well as any oth
er medical treatment influences the tumor, and on the other hand it in
fluences the whole body, which sometimes leads to unfavorable events (
increased rate of endometrial cancers during tamoxifen therapy vs, inc
rease of bone density in postmenopausal women). Therefore, hormonal ca
ncer treatment is often suspect. As unfavorable events are rare, and s
ince the benefit is convincing, doctors have to inform women about all
the pros and cons of this treatment option, which leads to well-infor
med and cooperative patients.